Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Blood Advances|December 22, 2020
CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma: an intent-to-treat comparisonPeter Dreger, Sascha Dietrich, Maria-Luisa Schubert, et al.Frontiers in Immunology|December 28, 2020
Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T CellsMingya Yang, Lei Wang, Ming Ni, et al.Frontiers in Immunology|June 14, 2021
Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell ImmunotherapyMingya Yang, Lei Wang, Ming Ni, et al.Cytotherapy|October 29, 2021
Response to extracorporeal photopheresis therapy of patients with steroid-refractory/-resistant GvHD is associated with up-regulation of Th22 cells and Tfh cellsMing Ni, Lei Wang, Yuntian Ding, et al.Leukemia|August 27, 2024
Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 studyPatrick Derigs, Maria-Luisa Schubert, Peter Dreger, et al.Nature Communications|July 29, 2026
A distinct CAR-T cell phenotype mediates therapeutic response at limited dosesSchayan Yousefian, Maria-Luisa Schubert, Anna Rita Minafra, et al.Frontiers in Immunology|April 6, 2019
Shaping of CD56bri Natural Killer Cells in Patients With Steroid-Refractory/Resistant Acute Graft-vs.-Host Disease via Extracorporeal PhotopheresisMing Ni, Lei Wang, Mingya Yang, et al.International Journal of Cancer|February 10, 2019
Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patientsSophia Stock, Rudolf Übelhart, Maria-Luisa Schubert, et al.Leukemia|November 20, 2024
Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT studyGuillermo Ortí, Christophe Peczynski, William Boreland, et al.Journal of Hematology & Oncology|July 22, 2023
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trialMaria-Luisa Schubert, Anita Schmitt, Angela Hückelhoven-Krauss, et al.Pageof 5